This new 271-page report from VPGMarketResearch.com provides a comprehensive analysis in the US endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.
During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2015-2019 US Endocrine Function Testing Market: Hospitals, Commercial Labs, Physician Offices is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.
Contains 271 pages and 18 tables
SIMILAR MARKET STUDIES
Summary Prothelia, Inc. (Prothelia) is a pharmaceutical company. The company develops and markets protein therapies for treatment of various diseases. Prothelias products pipeline include PRT-01 (Laminin-111), PRT-300, PRT-400, and PRT-500. Its PRT-400 and PRT-500 products are protein therapies for treatment of duchenne muscular dystrophy. The company has the support of academic ...
April 2015 | $250 | View Details >>
Guillain-Barre Syndrome Pipeline Review, H2 2015 Summary Global Markets Directs, Guillain-Barre Syndrome Pipeline Review, H2 2015, provides an overview of the Guillain-Barre Syndromes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Guillain-Barre Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ...
December 2015 | $2000 | View Details >>
EpiCast Report: Fibromyalgia Epidemiology Forecast to 2023 Summary Fibromyalgia, also known as fibromyalgia syndrome and fibrositis, is a common form of nonarticular rheumatism that is associated with chronic, widespread musculoskeletal pain, generalized tender joints, fatigue, and a long list of wide-ranging symptoms, such as fatigue, sleep disturbances, irritable bowel syndrome (IBS), headaches, ...
May 2015 | $3995 | View Details >>
Summary Apotex, Inc. (Apotex) is a pharmaceutical company. It carries out the production and marketing of a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacturing and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medicinal use. The company focuses on providing an ...
July 2015 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research